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Abstract 
HT-29 Glc -/+ cells originate from a human colon adenocarcinoma. These cells have been selected in a glucose-free culture medium 
and switched back in a glucose-containing medium. In this condition, they can spontaneously differentiate after confluency in 
enterocyte-like c lls according to the activity of the brush-border associated hydrolase dipeptidyl peptidase IV. Since L-arginine can 
generate polyamines which are necessary for cellular proliferation and also differentiation, and nitric oxide with reported anti-proliferative 
property, the metabolism of this amino acid was examined in proliferative and differentiated isolated HT-29 cells. Proliferative HT-29 
cells were characterized bymicromolar intracellular concentration f putrescine and millimolar concentration f spermidine and spermine. 
In these cells, L-arginine is converted to L-omithine and putrescine and to a minor part to nitric oxide and L-citrulline. Putrescine was 
taken up by HT-29 cells, leading to the production of a modest amount of spermidine. The diamine was slightly incorporated into cellular 
proteins and largely released in the incubation medium. The proliferative HT-29 cells take up spermidine and spermine but do not 
catabolize these polyamines and slightly released spermidine. Differentiation of HT-29 cells is not associated with change in intracellular 
polyamine content but is paralleled by an almost complete xtinction of de novo synthesis of putrescine (due to a dramatic decrease of 
ornithine decarboxylase activity) and by a reduced release capacity of putrescine. In contrast, putrescine net uptake and incorporation i to 
cellular proteins remained unchanged after differentiation. Furthermore, spermidine and spermine metabolism as well as the circulation of 
L-arginine in the nitric oxide synthase pathway were also not modified after differentiation. In conclusion, putrescine is the 
L-arginine-derived molecule, the metabolism of which is specifically and markedly modified when HT-29 cells move from proliferative to 
differentiated state. 
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1. Introduction 
In differentiated villus enterocytes i olated from intesti- 
nal mucosa, the catabolism of L-arginine appears to be 
intense resulting mainly in the production of L-ornithine, 
urea and L-citrulline which are released in the incubation 
medium [1]. L-ornithine generated through the step cat- 
alyzed by arginase is converted in isolated enterocytes to 
very low amounts of polyaraine [1,2] which are required 
for cell proliferation and differentiation [3-8]. Polyamine 
de novo synthesis involves the conversion of L-omithine 
into putrescine by ornithine decarboxylase and the further 
conversion of putrescine into spermidine and spermine 
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catalyzed respectively by spermidine synthase and sper- 
mine synthase. Intracellular polyamine concentration is 
tightly regulated and result in addition to de novo synthesis 
from uptake, incorporation into cellular proteins, 
catabolism, interconversion and release in the extracellular 
medium. Because the enterocytes are equipped with a low 
nitric oxide synthase activity [1,9,10], a modest part of 
L-arginine utilized by absorptive intestinal cells can circu- 
late in this metabolic pathway generating L-citrulline to- 
gether with nitric oxide. Nitric oxide is a gas with reported 
antiproliferative properties [11-18]. Thus, L-arginine is a 
precursor of metabolites which could induce opposed ef- 
fects on the cellular state. Intestinal cell proliferation and 
differentiation may be analyzed in HT-29 cells originating 
from a human colon carcinoma [19]. Differentiated HT-29 
Glc-  cells are selected in an hexose-free culture medium 
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[20]. In the present work, we used Glc- HT-29 cells which 
have been switched back in a o-glucose-containing medium 
[21]. These cells, called Glc -/÷ HT-29 cells, can sponta- 
neously differentiate after confluency in enterocyte-like 
cells presenting an apical brush border equipped with villin 
and dipeptidyl peptidase IV [21]. This enzyme has been 
recently demonstrated to strictly correlate with the pres- 
ence of a differentiated phenotype [22]. The aim of the 
present work was to detail L-arginine metabolism in the 
polyamine or nitric oxide synthase pathways in prolifera- 
tive or differentiated HT-29 Glc /÷ cells. 
(19:1, v /v )  and containing 10 mM Hepes, 1.3 mM CaC12, 
2 mM MgCI 2 and enriched with 10 mg/ml  bovine serum 
albumin (incubation medium). The isolated cells were 
counted with a hemacytometer and cellular viability was 
estimated by Trypan blue exclusion or by lactate dehydro- 
genase leakage tests. The 90-min incubation time did not 
affect cellular viability. Thus, from cells isolated at day 7 
or day 20, it was determined that 87 _+ 2% (n = 38) of 
total cells were viable at the onset of incubation, and 
85 +_ 2% (n = 33) of cells remained viable after 90 min 
incubation. 
2. Materials and methods 
2.1. Chemicals 
All the [14C]-labelled molecules were purchased from 
Amersham or New England Nuclear, except [Carboxyl- 
lac]inulin which was purchased from ICN Biomedicals. 
Gly-Pro p-nitroanilide, p-nitroaniline, carbamylphosphate, 
ornithine transcarbamylase, histamine, glycine methyl ester 
and Nw-nitro-L-arginine were from Sigma Chemicals. 
Arginase was from ICN Biomedicals. 6-(R,S)-5,6,7,8-te- 
trahydrobiopterin was obtained from Serva. Purified whole 
bovine casein was a generous gift from Dr. Le Bars 
(INRA). O,L-a-difluoromethyl ornithine (DFMO) was 
kindly provided by Marion Merrell Dow Research Insti- 
tute. 
2.2. HT-29 cell culture 
The human adenocarcinoma cell line HT-29 was first 
established in permanent culture by Fogh and Trempe [23]. 
The HT-29 Glc- cell subpopulation was selected by A. 
Zweibaum [20] by long-lasting rowth in a glucose-free 
medium. The subpopulation referred to as HT-29 Glc -/+ 
derives from HT-29 Glc cells grown in the absence of 
glucose for 36 passages and then switched back to 25 mM 
D-glucose medium [21]. The HT-29 Glc -/+ cells utilized 
in the present study were kindly provided by A. Servin 
(Facult6 de Pharmacie, Ch~tenay-Malabry, France) and 
cultured at 37°C under an atmosphere containing 10% CO 2 
in the standard DMEM medium containing 10% foetal calf 
serum, 25 mM D-glucose, 100 U/ml  penicillin and 100 
/zg/ml streptomycin. HT-29 Glc /+ cells were used be- 
tween passages 45 and 80 (1 passage very 7 days) and 
were seeded at a number of 0.40 × 10 6 cells per 25 cm 2 at 
day 0, and maintained for up to 23 days in culture. The 
culture medium was changed every day and cells were 
eventually isolated with a phosphate buffer saline (9.5 
mM, pH 7.4) without calcium and magnesium, and con- 
taining 1 g / l  EDTA and 0.25 g/1 trypsine. The isolated 
cells were washed with the phosphate buffer saline and 
resuspended in a Krebs-enseleit bicarbonate-buffered 
medium (pH 7.4) saturated with a mixture of Oz-CO 2 
2.3. HT-29 cell incubation 
Isolated HT-29 cells (1-6 X 10 6 cells) were incubated 
at 37°C in 120 /xl incubation medium containing the 
radioactive substrates. The radioactive metabolites were 
separated by reversed phase HPLC using a partisphere C18 
column (Whatman, Clifton, NJ), a 100-/zl loop injector 
and a buffer flow rate equal to 1.0 ml/min. The two 
buffers used are those described in the cited reference [24]. 
The gradient used for the separation of urea, L-ornithine 
and polyamine has been previously described [2]. L-citrul- 
line and L-glutamate were separated after treatment by the 
O-phtaldialdehyde rivatization method [25,26,9]. The in- 
corporation of [ 1,4-14 C]putrescine into trichloroacetic acid- 
precipitable material was assessed by incubating 2-8 X l0  6 
isolated HT29 cells in 200 /xl for 90 min at 37°C. At the 
end of incubation, the reaction was halted with 1 ml TCA 
10% and centrifuged 5 min at 2200 × g. The supernatant 
was discarded, and the pellet was rinced twice with TCA 
10% and then dissolved in 1 N NaOH for scintillation 
counting. 
2.4. Arginine, ornithine, glutamine and glutamate content 
of  HT-29 cells 
Arginine and ornithine cell content was determined in 
sonicated cells in the presence or absence of 2 U arginase 
in a 2 mM MnC12 solution as described [27]. The content 
of HT-29 cells in L-glutamine or L-glutamate was assayed 
in the deproteinized, neutralized cellular extract by the 
cited method [28]. 
2.5. Polyamine content of HT-29 cells 
HT-29 cells were treated with 2% perchloric acid and 
the extract was injected on HPLC for the separation of 
putrescine, spermidine and spermine. Eluent fractions were 
examined for their fluorescence intensity after treatment 
with the O-phtaldialdehyde reagent [29]. 
2.6. HT-29 protein determination 
Protein content of the HT-29 cells was determined by 
the method of Lowry [30]. The protein content of HT-29 
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cells were similar at day 7' (212.7_ 13.1 /zg/106 cells, 
n = 26) and at day 20 (252.4 _ 14.0/zg/106 cells, n = 28). 
2.7. Uptake studies 
Uptake of amino acids or polyamines by HT-29 cells 
was determined by incubating 120 /zl of the incubation 
medium containing 0.2-0.4 × 10 6 cells, 2 mM D-glucose 
and the radioactive amino acids or polyamines. The net 
uptake was determined by centrifuging the cells through an 
oil layer as described [2]. In all experiments, the net uptake 
was corrected for the apparent volume of distribution of 30 
/zM L-[1-14C]glucose. The intracellular volume of HT-29 
cells was determined as the L-glucose diffusion space after 
correction for the extracellular fluid estimated by the inulin 
space using 100 /zM [carboxyl-14C]inulin. This L-glucose 
space was equal to 0.75 + 0.06 /.tl/106 cells (n = 6) for 
the cells isolated at day 7 and incubated at 37°C, and to 
1.11 _ 0.16 /zl/106 cells (n = 6) for the cells isolated at 
day 20. The inulin space was identical in cells isolated at 
day 7 or day 20 representing 0.38 + 0.03 /zl/106 cells 
(n = 4). The distribution space of L-glucose when mea- 
sured at 4°C represented 71+ 7% (n = 9) of the L-glucose 
space measured at 37°C. 
2.8. Release of polyamines by HT-29 cells 
HT-29 cells (5 -10× 106 cells) were prelabelled in 
incubation medium containing 2 mM D-glucose with [1,4- 
14C]putrescine or [14C]spermidine for 60 rain at 37°C, and 
then rinced once with the same incubation medium but 
containing no polyamine. Then the cells (0.2-0.4 × 10 6 
cells in 120/~1 incubation medium) were placed on 150/~l 
silicon oil, itself placed on 50/zl HCI-CsCI solution and 
immediately centrifuged (3 min at 12000 ×g)  or incu- 
bated at 37°C before centrifiagation. 60 p~l aliquote of the 
incubation medium was counted by liquid scintillation, and 
the radioactive cell content was determined at zero time in 
the cell pellet. Release was. expressed after deduction of 
radioactivity recovered at zero time in the incubation 
medium as a percentage of the initial cell content. (This 
later represents 17.6 ___ 4.1 pmoi/106 cells for putrescine 
(n = 8) and 71.7 _+ 20.1 pmol/106 cells for spermidine, 
n = 8.) 
#M FAD, 10 /xM FMN and 10/xM 6-(R,S)-5,6,7,8-tetra- 
hydrobiopterin. Ornithine decarboxylase activity was de- 
termined in sonicated HT-29 cells which have been incu- 
bated for 60 min at 30°C in 100/zl of a Hepes-NaOH (50 
mM, pH 7.2) buffer containing 0.5 mM dithiothreitol, 0.2 
mM pyridoxal 5'-phosphate and L-[1-14C]ornithine. The 
radioactive CO 2 was assayed as described [2]. Last, transg- 
lutaminase activity was determined using sonicated HT-29 
cells which have been incubated 60 min at 37°C in 200 /zl 
of a Tris-HC1 buffer (50 mM, pH 9.0) containing 1 mg 
casein and 0.5 mM [1,4-14C]putrescine. At the end of the 
incubation, the reaction was halted with 1 ml 10% tri- 
chloroacetic acid and after centrifugation at2200 × g for 5 
min, the pellet was rinced twice with trichloroacetic acid 
and eventually dissolved in 0.5 ml 1 N NaOH before 
counting by liquid scintillation. 
2.10. Presentation of results 
The results were expressed as the mean (±S.E.M.) 
together with the number of individual experiments per- 
formed with HT-29 cells isolated at different passages (n). 
The production of metabolites from radioactive precursors 
was calculated by reference to the specific activity of the 
precursors in the incubation medium and corrected by the 
isotopic dilution due to the presence of non-radioactive 
endogenous precursors. The statistical significance of dif- 
ferences between mean values was assessed by Student's 
t-test. 
3. Results 
3.1. Growth time course and dipeptidyl peptidase IV activ- 
ity 
After a lag period of 24 h, the growth time course 
followed an exponential curve up to the seventh day after 
the beginning of the cell culture (Fig. 1). The doubling 
time during this period was calculated to be equal to 31 h. 
Then, the growth time course was approximately inear. 
DPPIV activity was increased more than 3-fold in HT-29 
cells grown in culture for 20 days when compared with 
activity obtained at day 7 (Fig. 1). 
2.9. Enzyme activities 
Dipeptidyl peptidase IV 'was assayed using the method 
of Nagatsu [31]. To determine arginase activity, sonicated 
HT29 cells were incubated for 60 min at 37°C in 100 /zl 
Tris-HC1 buffer (100 mM, pH 7.2) containing 1 mM 
L-[guanido-lnC]arginine and 2 mM MnC12. Nitric oxide 
synthase activity was determined in sonicated HT29 cells 
incubated for 60 min at 3:°C in 100 /zl of a Tris-HC1 
buffer (100 mM, pH 7.2) containing 1 mM dithiothreitol, 
50 /zM L-[guanido-14C]arginine and 1 mM NADPH, 10 
3.2. L-Ornithine, L-arginine, L-glutamine and polyamine 
cell content 
The cell contents in polyamines and its precursors were 
evaluated. The intracellular L-ornithine pool was similar at 
day 7 and day 20, and represented 935_  249 pmol/106 
cells (n = 8). The L-arginine content of isolated HT-29 
cells at day 7 or day 20 amounted to 5980__ 1237 
pmol/106 cells (n = 4). Ornithine and arginine cell con- 
tents were not affected by the 90 min incubation at 37°C. 
The L-glutamine intracellular pool in HT-29 cells isolated 
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at confluency or after 20 days in culture was equal to 
159 ___ 111 pmol /106 cells (n = 8). The L-glutamate intra- 
cellular pool amounted to 4568 +980 pmol /106 cells 
(n = 8). The putrescine cell content was close to the limit 
of detection both at day 7 and day 20, representing 40 _ 19 
pmol/106 cells (n= 8). Spermidine cell content repre- 
sented 833 + 120 pmol/106 cells (n = 7) at day 7 and 
780_  123 pmol /106 cells (n = 7) at day 20. Spermine 
cell content averaged 1859 + 659 pmol /106 cells (n = 7) 
at day 7 and 1920 + 498 pmol /106 cells (n = 7) at day 
20. 
3.3. L-Ornithine metabolism in HT-29 cells 
In the presence of 1 mM L[U-14C]  ornithine, a net 
uptake of the amino acid was registred (Table 1). This 
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Fig. 1. Growth time course and dipeptidyl peptidase IV activity of HT-29 
cells. The upper panel illustrates the growth time course of HT-29 cells 
which were seeded at a concentration f 0.40× 10 6 cells in 5 ml culture 
medium and maintained for different periods of time in this latter up to 
23 days. The lower panel illustrates dipeptidyl peptidase IV activity in 
HT-29 cells. DPPIV activity is expressed relative to the value found at 
day 5 (i.e., 13.1 5:3.4 mU/mg protein, n = 7). Mean values (+S.E.M.) 
are shown and represent 3-11 individual experiments. S.E.M. is indicated 
only if larger than symbol size. a: P < 0.01 vs. day 5; b: P < 0.005 vs. 
day 5. 
Table 1 
L-Ornithine metabolism in HT-29 cells isolated at day 7 or day 20 
Time of cell isolation 
Day 7 Day 20 
pmol/106 cells/90 min 
1 mM L-[U-]4C]omithine uptake 
Production of putrescine from 
1 mM L-[U-14C]ornithine 
Production of spermidine from 
1 mM L-[U- 14 C]ornithine 
8642+ 1016(5) 5166+ 192(4) a 
443+ 142(4) 665:21(4) a
44-t- 19(5) not detected 
HT-29 cells were isolated after 7 or 20 days in culture and incubated at 
37°C in the presence of 1 mM radioactive omithine. The net uptake was 
corrected for the distribution space of L-glucose. Mean values ( + S.E.M.) 
are shown together with the number of individual experiments. 
a p < 0.05 vs. day 7. 
uptake was significantly lower at day 20 than at day 7. 
Since the L-ornithine net uptake represents the sum of 
transport and binding of this cationic amino acid, the cells 
were incubated at 4°C to estimate the part represented by 
the amino acid binding. 
The binding of L-ornithine represented 495 + 133 
pmol /106 ce l l s /90 min (n = 9). From these data, it can 
be calculated that after 90 min incubation at 37°C, L- 
ornithine accumulated 15-fold in cells at confluency and 
9-fold in cells maintained in culture for 20 days. This net 
uptake was accompagnied by a net production of pu- 
trescine at day 7 and day 20, but the production at day 20 
represented 15% of the value recorded at day 7 (Table 1). 
A net production of spermidine from L-[U-14C]ornithine 
was detected at confluency but not at day 20. The addition 
of 1 mM methionine used as a precursor of decarboxylated 
S-adenosylmethionine i  the incubation medium did not 
increase spermidine production from the precursor (n = 5). 
Ornithine decarboxylase (ODC) activity was dramati- 
cally reduced between day 7 and day 20. ODC activity was 
approximately 10 times higher at confluency as compared 
to the cells maintained in culture for 20 days (Fig. 2). 
Furthermore, in the presence of putrescine, spermidine and 
spermine used at concentrations where it approximately 
mimicks intracellular concentrations, ODC activity was 
inhibited by 19 ___ 4% (n = 6) at confluency, but a 73 + 6% 
(n = 6, P < 0.001 vs. basal) inhibition was recorded at 
day 20. DFMO used at 10 mM concentration i hibited the 
decarboxylation f 200/zM L-[1-14C]ornithine by 87 _ 9% 
(n = 4) at day 7 and by 74 + 6% (n = 4) at day 20. 
The concentration of L-ornithine in the foetal calf serum 
used for the preparation of HT-29 culture medium was 
found to be equal to 62 .5_  2.2 /zM (n = 3). Thus, the 
calculated final concentration of L-ornithine in the culture 
medium is equal to 6.25 /~M. 
3.4. L-Arginine metabolism in HT-29 cells 
In the presence of 1 mM L-[U-14C]arginine, a net 
uptake of the amino acid was recorded (Table 2). The 
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Fig. 2. Ornithine decarboxylase activity in HT-29 cells isolated at day 7 
or day 20. Omithine decarboxylase activity was determined in HT-29 cell 
homogenates at 30°C as the production of radioactive CO 2 from 20 or 
200 /zl [1-14C]ornithine. Mean values (+ S.E.M.) are shown and repre- 
sent 6-12 individual experiments. Day 7: a: P < 0.005 vs. ornithine 20 
IzM; day 20: b: P < 0.05 vs. ornitlfine 20/xM; c: P < 0.005 vs. ornithine 
200 /xM alone. 
arginine net uptake was slightly but significantly smaller 
after 20 days in culture when compared with cells at 
confluency. The net uptake of L-arginine at 4°C repre- 
sented 519_ 114 pmol/106 cells/90 min (n = 9). After 
90 min incubation at 37°C, I.-arginine accumulated approx- 
imately 11-fold into HT-29 cells isolated at confluency and 
8-fold in cells isolated after 20 days in culture. This 
accumulation coincided with a production of L-omithine 
and urea (Table 2). These productions were similar at day 
7 and day 20. The production of radioactive L-citrulline 
from 1 mM L-[guanido-14C]arginine through the reaction 
catalyzed by nitric oxide synthase in HT-29 cells was close 
to the limit of detection both at day 7 and day 20 (Table 
2). Arginase and nitric oxide synthase activities were both 
detected at similar levels at day 7 and day 20. 
Arginase activity represented 152.1 _+ 43.3 pmol/106 
cells/90 min (n = 5) at day 7, and 214.2 _+ 75.9 pmol/106 
cells/90 min (n = 5) at day 20. Nitric oxide synthase 
represented 1.1 _+ 0.5 pmol/106 cells/90 min (n = 5) at 
day 7 and 1.6 ___ 0.9 pmol/106 cells/90 min (n = 3) at 
day 20. The presence of 100 /zM Nw-nitro-L-arginine 
induced a 48 + 7% (n = 3) inhibition of the nitric oxide 
synthase basal activity. A sizeable production of putrescine 
derived from 1 mM L-[U-14C]arginine was detected at day 
7 (Table 2), but not at day 20. No production of spermi- 
dine from 1 mM L-[U-~4C]arginine was detected at day 7 
or at day 20 (n=6)  even in the presence of 1 mM 
L-methionine. 
3.5. L-Glutamine metabolism in HT-29 cells 
In HT-29 cells isolated at day 7 and incubated in the 
presence of 2 mM L-[U-14C]glutamine, 16633 +3553 
pmol/106 cells/90 min (n = 3) were utilized leading to 
the production of 11 340 + 1683 pmol/106 cells/90 min 
(n = 3) of L-glutamate and to 126 _ 41 pmol/106 cells/90 
min (n = 6) of L-ornithine. At day 20, glutamine utiliza- 
tion (14080_+ 2476 pmol/106 cells/90 min, n = 3), L- 
glutamate production (7087 + 2055 pmol/106 cells/90 
min, n = 3) and L-ornithine production (110_  39 
pmol/106 cells/90 min, n = 3) were similar to data ob- 
tained at day 7. No production of putrescine, spermidine 
and spermine could be detected (n = 5). 
3.6. Uptake and metabolism of polyamines 
The kinetics of 10 ~M putrescine uptake by HT-29 
cells isolated at confluency or after 20 days in culture are 
shown in Fig. 3, revealing similar plots at both stages. The 
part represented by the cellular binding of putrescine was 
evaluated at 4°C. At that temperature, HT-29 cells take up 
5.8 + 2.5 pmol/106 cells/90 min (n = 3). After 90 min 
Table 2 
L-Arginine metabolism in HT-29 cells isolated at day 7 or day 20 
Time of cell isolation 
Day 7 Day 20 
pmol/106 cells/90 min 
1 mM L-[U-14 C]arginine uptake 
Production of urea from 
1 mM L-[guanido-J4C]arginine 
Production of L-omithine from 
1 mM L-[U-t4C]arginine 
Production of L-citrulline from 
1 mM L-[guanido- 14 C]arginine 
Production of putrescine from 
1 mM L-[U-14C]arginine 
6447 + 343(6) 5018 + 395(4) a 
8484-312(6) 755+177(4) 
584 + 198(5) 389+ 12(4) 
28+ 14(5) 44+20(3) 
162 + 63(4) not detected 
HT-29 cells were isolated after 7 or 20 days in culture and incubated at 
37°C in the presence of 1 mM radioactive L-arginine. The net uptake was 
corrected for the distribution space of L-glucose. Mean values (+ S.E.M.) 
are shown together with the number of individual experiments. 
a p < 0.05 vs. day 7. 
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Fig. 3. Kinetic of putrescine net uptake by HT-29 cells isolated at day 7 
or day 20. HT-29 cells were isolated after 7 or 20 days in culture and 
incubated at 37°C in the presence of 10 /xM [1,4-14C]putrescine. The 
measured net uptake of radioactive putrescine was corrected for the 
distribution space of L-glucose. Mean values (+S.E.M.) are shown and 
represent 3 individual experiments. 
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incubation at 37°C, putrescine accumulated 13-fold in 
HT-29 cells at confluency or in cells isolated in differenti- 
ated state. The net uptakes of spermine and spermidine 
were similar in HT-29 cells isolated at day 7 or day 20 
(Table 3). The binding of polyamines were similar at day 7 
or day 20 representing 12_ 5 pmol/106 cells/90 min 
(n = 7) for spermidine and 50 ___ 14 pmol/106 cells/90 
min (n = 8) for spermine. HT-29 cells accumulated sper- 
midine 25-fold and spermine 17-fold. The metabolism of 
polyamines taken up by HT-29 cells were then investi- 
gated. When HT-29 cells were incubated in the presence of 
10 /xM putrescine for 90 min at 37°C, no measurable 
amount of putrescine was degraded by cells at day 7 or at 
day 20 (less than 10 pmol/106 cells, n = 5). A sizeable 
amount of spermidine was produced from putrescine at 
confluency and in the differentiated state. This production 
was equal to 2.4 + 1.0 pmol/106 cells/90 min (n = 3) at 
day 7 and to 3.8 _4- 1.9 pmol/106 cells/90 min (n = 3) at 
day 20. The presence of 1 mM L-methionine in the incuba- 
tion medium did not increase the amount of spermidine 
produced (108 + 11% of the basal production, n = 3). A 
measurable amount of putrescine was incorporated in TCA 
precipitable material derived from intact HT-29 cells. Us- 
ing 10 /zM radioactive putrescine, it was found that cells 
isolated at day 7 or day 20 incorporated 2.4_+0.8 
pmol/106 cells/90 min (n = 8). This incorporation repre- 
sented 3% of the uptake of the diamine. Furthermore, 
putrescine incorporation was dose-related since in the pres- 
ence of 500 /zM putrescine, HT-29 cells used at day 7 or 
day 20 incorporated 119.8 _+ 33.1 pmol/106 cells/90 min 
(n = 8). Last, this incorporation coincided with the pres- 
ence of a detectable transglutaminase activity in ho- 
mogenate obtained from cells isolated at day 7 or day 20. 
Since transglutaminase requires the presence of calcium 
for catalysis, the transglutaminase activity assayed in the 
presence of 0.5 mM [1,4-14C]putrescine can be calculated 
by difference between the data obtained at 37°C in the 
presence of 1 mM Ca 2+ (i.e., 52.6_+4.1 pmol/106 
cells/60 min, n = 7) and in the presence of 0.5 mM 
EGTA (i.e., 13.6_+ 3.6 pmol/106 cells/60 min, n = 4, 
P<0.001 vs. 1 mMCa2+). At 4°C in the presence of 1 
Table 3 
Putrescine, spermidine and spermine net uptake by HT-29 cells isolated at 
day 7 or day 20 
Time of cell isolation 
Day 7 Day 20 
pmol/106 cells/90 min 
10/zM [1,4-'4C]putrescine net uptake 80+ 3(3) 74+ 11(3) 
10/zM [14C]spermidine t uptake 146+ 16(3) 144+ 17(3) 
10/zM [14C]spermine t uptake 136+22(3) 147+ 15(4) 
HT-29 cells were isolated after 7 or 20 days in culture and incubated at 
37°C in the presence of 10 o,M radioactive putrescine, spermidine or 
spermine. The measured net uptakes of polyamines were corrected for the 
distribution space of L-glucose. Mean values (+S.E.M.) are shown 
together with the number of individual experiments. 
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Fig. 4. Release of putrescine and spermidine from HT-29 cells isolated at 
day 7 or day 20. HT-29 cells were isolated at confluency or after 20 days 
in culture and labelled with 10 /zM [1,4-14C]putrescine or 10 /xM 
[)4C]spermidine for 60 min at 37°C. Then the cells were washed and 
incubated in a non-radioactive incubation medium at 37°C for different 
periods of time. The amounts of polyamines recovered in the incubation 
medium were corrected for the value recorded at the zero time of 
incubation and expressed as the percentage of the initial cell content. 
Mean values (+S.E.M.) are shown and represent 4 individual experi- 
ments. Putrescine release after 10 min: P < 0.05 day 20 vs. day 7; 
putrescine release after 20 or 30 min: P < 0.025 day 20 vs. day 7. 
mM Ca 2+, transglutaminase activity represented 8.4 +_ 3.8 
pmol/106 cells/60 min (n = 4). Transglutaminase activ- 
ity was thus found to be equal to 39 pmol/106 cells/60 
min. Glycine methyl ester and histamine when tested at a 
10 mM concentration i the presence of 1 mM Ca 2+ 
inhibited transglutaminase activity by 57 _+ 6% (n = 9). 
When the cells were incubated in the presence of 10 /xM 
[14C] spermidine or 10 /~M [14C] spermine, no sizeable 
amount of the polyamines was degraded by the cells at day 
7 or day 20 (less than 10 pmol/106 cells/90 min, n = 4) 
in the absence or presence of 1 mM L-methionine. 
3.7. Release of polyamines by prelabelled HT-29 cells 
HT-29 cells were preincubated for 60 min at 37°C in 
the presence of 10/~M putrescine. Then, they were washed 
and resuspended in a non radioactive medium and incu- 
bated at 37°C. In such conditions, the cells release in a 
time-dependent manner radioactivity in the incubation 
medium (Fig. 4). Cells isolated at confluency released 
more than 60% of the initial cellular adioactive putrescine 
content after 30 min incubation at 37°C. Cells isolated in a 
more differentiated state after being maintained 20 days in 
culture released approximately one-third less radioactive 
putrescine when compared with their day 7 counterpart. 
When the HT-29 cells were prelabelled with radioactive 
spermidine following the same experimental pattern, the 
release of radioactive spermidine in the incubation medium 
was much more modest, representing approximately 10% 
of the initial cellular content. In contrast with putrescine 
release, the release of spermidine was similar at both 
stages of differentiation. 
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4. Discussion 
In our hands, HT-29 Glc - / -  cells which have been 
selected on an hexose-free medium could differentiate in
enterocyte-like c lls when 1:hey were cultured back for 20 
days in a D-glucose-containing culture medium. The tested 
marker of differentiation was the brush-border associated 
hydrolase dipeptidyl peptidase IV which expression exclu- 
sively increases in cells which display an enterocytic dif- 
ferentiation [22]. This enzymic activity was increased more 
than 3 times in enterocyte-like c lls and the differentiation 
was paralleled by a marked decrease of cellular prolifera- 
tive activity. HT-29 cells require an absolute need of 
polyamines for optimal proliferation. In the presence of 
difluoromethylornithine (i. ., an inhibitor of ornithine de- 
carboxylase which suppress endogenous ynthesis of 
polyamines), the proliferation of HT-29 cells is almost 
completely suppressed [32], indicating that the polyamines 
contained in the serum and transported inside cells are not 
sufficient o permit optimal cellular proliferation. Indeed, 
in this paper, Gamet et al. showed that 10 /zM exogenous 
putrescine in the presence of difluoromethylornithine re- 
store nearly normal cellular growth. However, it cannot be 
concluded from these data if it is an effect of putrescine 
per se, or if putrescine is active on growth through the 
generation of spermidine and spermine which are known 
to play a role in cellular proliferation. For instance, sper- 
midine and spermine depletion in colon carcinoma cells 
were found to decrease the expression of genes associated 
with cellular growth [33,3,4]. Our data indicate that pu- 
trescine is converted by HT-29 cells to a relatively low 
amount of spermidine when compared with spermidine 
cell content. 
Interestingly, putrescine has been reported to stimulate 
by itself DNA synthesis in immature crypt intestinal ep- 
ithelial IEC-6 cells [35]. In the culture medium, the major 
precursor of polyamines i lL-arginine which is present at a 
concentration f 0.4 mM and can be degraded to L-ornithine 
and urea by growing cells. The L-ornithine formed is then 
transformed into putrescine by a very high ornithine decar- 
boxylase activity. Indeed, ornithine decarboxylase activity 
is considered as a proto-oneogene c ntral for regulation of 
cell growth and malignant ransformation [36]. Although 
L-ornithine was taken up by HT-29 cells and converted to 
putrescine by ornithine decarboxylase, L-ornithine is quan- 
titatively a minor precursor of putrescine since its mea- 
sured concentration i  the culture medium represents only 
6 /xM. In contrast, L-glutarnine, the concentration f which 
in the culture medium is equal to 4 mM and which is 
highly utilized by proliferative cells, giving rise to high 
amount of L-glutamate, could represent through the pro- 
duction of L-ornithine a precursor of putrescine. However, 
the production of L-ornithine from 2 mM L-glutamine 
represents only 20% of the production recorded in the 
presence of 1 mM L-arginine. 
Despite the fact that putrescine was accumulated 13-fold 
in confluent cells and was synthetized endogenously, the 
intracellular putrescine content was found to be micromo- 
lar. This is not due to a high incorporation of putrescine 
into HT-29 cells. This modest incorporation corresponded 
to a Ca2+-dependent and histamine-and glycine methyl 
ester-inhibitable transglutaminase activity. These two 
agents are transglutaminase competitive inhibitors in other 
cell-types [37]. The low putrescine cell content was rather 
due to a large release capacity of the diamine in the 
incubation medium. This release capacity can be related to 
the cytosolic location of putrescine [38,39] and to a cyto- 
toxic effect of excess putrescine [40]. It is considered that 
putrescine release is essential for the regulation of cellular 
concentration [41]. At difference, the more efficient system 
of spermidine and spermine uptake and the modest release 
of spermidine in the incubation medium could explain the 
millimolar intracellular concentrations of the 2 polyamines. 
This would be related to the intraorganelle localization of 
the polyamines [39]. Last, proliferative cells were found to 
metabolize L-arginine in the nitric oxide synthase pathway, 
but the circulation of the amino acid through this enzyme 
represented only 3% of the flux of L-arginine in the 
arginase pathway and this result was related with a low 
NO synthase activity. Nitric oxide synthase has been de- 
tected in normal colonocytes [9] and in normal enterocytes 
[1,9,10]. Although reported as antiproliferative, this 
metabolic pathway was unaltered in the differentiated and 
less proliferative HT-29 cells. Similarly, transglutaminase 
pathway was not modified in differentiated cells. This is in 
contrast with published ata obtained with other cell types 
which reported that cellular differentiation is paralleled by 
increased transglutaminase activity [42,43]. Putrescine, 
spermidine and spermine uptake were not modified in 
differentiated HT-29 cells when compared with their pro- 
liferative counterpart. Indeed, the main metabolic hanges 
observed in differentiated cells are related to putrescine 
synthesis and release. First, the capacity to generate the 
diamine was abolished. This was not due to any marked 
alteration of L-arginine transport or capacity to generate 
L-ornithine through arginase activity but to (1) a spectacu- 
lar decrease of ornithine decarboxylase activity and (2) a 
marked retroinhibition of enzymic activity by endogenous 
polyamines. Although ornithine decarboxylase expression 
is regulated at multiple levels in eukaryotic ells [6], the 
main type of regulation in IEC-6 intestinal crypt ceils is 
post-translational [44]. The determinant implicated in the 
loss of ornithine decarboxylase activity in differentiated 
cells is not known, but since polyamine exerts strong 
feedback control on enzymic activity [45], it is possible 
that the decrease in ornithine decarboxylase activity could 
be due -in part at least - to an increase of putrescine in 
the culture medium due to the synthesis from L-arginine 
followed by the release of the diamine in the incubation 
medium. 
Putrescine release was diminished in differentiated HT- 
29 cells. This result can be related to a recent work 
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showing that when endogenous synthesis of putrescine is 
reduced by difluoromethylornithine  IEC-6 intestinal 
crypt cell, the diamine uptake capacity is not modified, but 
the putrescine release is diminished [46]. 
In conclusion, putrescine micromolar concentration 
would result from uptake, endogenous synthesis from L- 
arginine and ample release of the diamine in the culture 
medium. The apparition of a differentiated and less prolif- 
erative phenotype is characterized by similar spermidine 
and spermine metabolic apacities and similar metabolism 
of L-arginine in the nitric oxide synthase pathway. In 
contrast, putrescine -although taken up and incorporated 
as in proliferative cells -is synthetized to a very low level 
by differentiated cells. This could correspond to a different 
putrescine requirement in differentiated state vs. confluent 
state. Furthermore, the reduced release of the diamine in 
the incubation medium represent probably a regulatory 
process to maintain a steady-state putrescine intracellular 
content. Experiments are in progress in our laboratory to 
test the hypothesis of a causal relationship between transi- 
tion of HT-29 cells from proliferative to differentiated 
phenotype and modification of putrescine metabolism. 
Acknowledgements 
The authors are grateful to Hubert Lerminiaux and 
Suzana de Carvalho Amorim for technical help and to 
Fran~oise Rivalland and Claude Dacheux for secretarial 
help. 
References 
[1] Blachier, F., Darcy-Vrillon, B., Sener, A., Dure, P.H. and Malaisse, 
W.J. (1991) Biochim. Biophys. Acta 1092, 304-310. 
[2] Blachier, F., M'Rabet-Touil, H., Posho, L., Morel, M.T., Bernard, 
F., Darcy-Vrillon, B. and Du~e, P.H. (1992) Biochim. Biophys. Acta 
1175, 21-26. 
[3] Tabor, C.W. and Tabor, H. (1984) Ann. Rev. Biochem. 53,749-790. 
[4] Pegg, A.E. (1988) Cancer Res. 48, 759-774. 
[5] Seiler, N., Sarhan, S., Grauffel, C., Jones, R., KnOdgen, B. and 
Moulinoux, J.P. (1990) Cancer Res. 50, 5077-5083. 
[6] Heby, O. and Persson, L. (1990) Trends Biochem. Sci. 15, 153-158. 
[7] Nishioka, K. (1993) Cancer Res. 53, 2689-2692. 
[8] Pegg, A.E. and McCann, P.P. (1982) Am. J. Physiol. 243, C212- 
C221. 
[9] M'Rabet-Touil, H., Blachier, F., Morel, M.T., Darcy-Vrillon, B. and 
Dufe, P.H. (1993) FEBS Lett. 331, 243-247. 
[10] Tepperman, B.L., Brown, J.F. and Whittle, B.J.R. (1993) Am. J. 
Physiol. 265, G214-G218. 
[11] Hibbs, J.B., Taintor, R.R., Vavrin, Z. and Rachlin, E.M. (1988) 
Biochem. Biophys. Res. Commun. 157, 87-94. 
[12] Garg, U.C. and Hassid, A. (1990) Biochem. Biophys. Res. Commun. 
171,474-479. 
[13] Lepoivre, M., Chenais, B., Yapo, A., Lemaire, G., Thelander, L. and 
Tenu, J.P. (1990) J. Biol. Chem. 265, 14143-14149. 
[14] Nguyen, T., Brunson, D., Crespi, C.L., Penman, B.W., Wishnok, 
J.S. and Tannenbaum, S.R. (1992) Proc. Natl. Acad. Sci. USA 89, 
3030-3034. 
[15] Goureau, O., Lepoivre, M., Becquet, F. and Courtois, Y. (1993) 
Proc. Natl. Acad. Sci. USA 90, 4276-4280. 
[16] Huot, A.E., Moore, A.L., Roberts, J.D. and Hacker, M.P. (1993) 
Immunol. Invest. 22, 319-327. 
[17] Firnhaber, C. and Murphy, M.E. (1993) Am. J. Physiol. 265, 
R518-R523. 
[18] Ioannidis, I. and De Groot, H. (1993) Biochem. J. 296, 341-345. 
[19] Zweibaum, A., Laburthe, M., Grasset, E. and Louvard, D. (1991) in 
The gastrointestinal system IV: Use of cultured cell lines in studies 
of intestinal cell differentiation a d function (Field, M. and Frizzell, 
R.A., eds.), pp. 223-255, American Physiological Society, Washing- 
ton, D.C. 
[20] Zweibaum, A., Pinto, M., Chevalier, G., Dussaulx, E., Triadou, N., 
Lacroix, B., Haffen, K., Brun, J.L. and Rousset, M. (1985) J. Cell. 
Physiol. 122, 21-29. 
[21] Lesuffleur, T., Kornowski, A., Augeron, C., Dussaulx, E., Barbat, 
A., Laboisse, C. and Zweibaum, A. (1991) Int. J. Cancer 49, 
731-737. 
[22] Darmoul, D., Lacasa, M., Baricault, L., Marguet, D., Sapin, C., 
Trotot, P., Barbat, A. and Trugnan, G. (1992) J. Biol. Chem. 267, 
4824-4833. 
[23] Fogh, J. and Trempe, G. (1975) in Human Tumor Cells in vitro: 
New Human Tumor Cell Lines (Fogh, J., ed.), pp. 115-141, Plenum 
Press, New York. 
[24] Seiler, N. and KnSdgen, B. (1980) J. Chromatogr. 221,227-235. 
[25] Morineau, G., Azoulay, M. and Frappier, F. (1989) J. Chromatogr. 
467, 209-216. 
[26] Blachier, F., M'Rabet-Touil, H., Darcy-Vrillon, B., Posho, L. and 
Du~e, P.H. (1991) Biochem. Biophys. Res. Commun. 177, 1171- 
117% 
[27] Blachier, F., M'Rabet-Touil, H., Posho, L., Darcy-Vrillon, B. and 
Du~e, P.H. (1993) Eur. J. Biochem. 216, 109-117. 
[28] Bernt, E. and Bergmeyer, H.U. (1974) in Methods of Enzymatic 
Analysis: L-Glutamate-UV-assay with Glutamate Dehydrogenase and 
NAD. (Bergmeyer, H.U. ed) pp. 1704-1708, Academic Press, New 
York. 
[29] Blachier, F., Mourtada, A., Sener, A. and Malaisse, W.J. (1989) 
Endocrinology 124, 134-141. 
[30] Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951) 
J. Biol. Chem. 193, 265-275. 
[31] Nagatsu, T., Hino, M., Fuyamada, H., Hayakawa, T., Sakakibara, S., 
Nakagawa, Y. and Takemoto, T. (1976) Anal. Biochem. 74, 466- 
476. 
[32] Garnet, L., Cazenave, Y., Trocheris, V., Denis-Plouxviel, C. and 
Murat, J.C. (1991) Int. J. Cancer 47, 633-638. 
[33] Celano, P., Baylin, S.B. and Casero, R.A. (1989) J. Biol. Chem. 
264, 8922-8927. 
[34] Celano, P., Berchtold, C.M., Giardiello, F.M. and Casero R.A. 
(1989) Biochem. Biophys. Res. Commun. 165, 384-390. 
[35] Ginty, D.D., Osborne, D.L and Seidel, E.R. (1989) Am. J. Physiol. 
257, G145-G150. 
[36] Auvinen, M., Paasinen, A., Andersson, L.C. and HiSlttii, E. (1992) 
Nature 360, 355-358. 
[37] Bersten, A.M., Ahkong, Q.F., Hallinan, T., Nelson, S.J. and Lucy, 
J.A. (1983) Biochim. Biophys. Acta 762, 429-436. 
[38] Snyder, R.D. (1989) Biochem. J. 260, 697-704. 
[39] Malaisse, W.J., Blachier, F., Mourtada, A., Camara, J., Albor, A., 
Valverde, I. and Sener, A. (1989) Mol. Cell. Endocrinol. 67, 81-91. 
[40] Tome, M.E., Fiser, S.M. and Gerner, E.W. (1994) J. Cell. Physiol. 
158, 237-244. 
[41] Seiler, N. and Dezeure, F. (1990) Int. J. Biochem. 22, 211-218. 
[42] Chen, K.Y. (1984) Mol. Cell. Biochem. 58, 91-97. 
[43] Peterson, L.L. and Wuepper, K.D. (1984) Mol. Cell. Biochem. 58, 
99-111. 
[44] Ginty, D.D., Marlowe, M., Pekala, P.H. and Seidel, E.R. (1990) 
Am. J. Physiol. 258, G454-G460. 
[45] Li, X. and Coffino, P. (1993) Mol. Cell. Biol. 13, 2377-2383. 
[46] Mc Cormack, S.A. and Johnson, L.R. (1991) Exp. Cell. Res. 193, 
241-252. 
